Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic target.

Ferrari, Marina; Wang, Li; Hoeppner, Luke; Hahm, Eunsil; Yu, Jindan; Kuzel, Timothy; Mansini, Adrian

Ferrari, Marina; Wang, Li; Hoeppner, Luke; Hahm, Eunsil; Yu, Jindan; Kuzel, Timothy; Mansini, Adrian.

Afiliación

Hoeppner L; University of Minnesota.
Yu J; Emory University.
Mansini A; Rush University Medical Center.

Res Sq ; 2023 Jun 09.

Article en En | MEDLINE | ID: mdl-37333086

Palabras clave

CRPC; MD2; Prostate Cancer; biomarker

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Res Sq Año: 2023 Tipo del documento: Article